Placental growth factor at 24–28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial by Marta Ricart, Erika Bonacina, Pablo Garcia‐Manau, Monica López, Sara Caamiña, Àngels Vives, Eva Lopez‐Quesada, Anna Maroto, Laura deMingo, Elena Pintado, Roser Ferrer‐Costa, Lourdes Martín, Alicia Rodriguez‐Zurita, Esperanza Garcia, Mar Pallarols, Laia Pratcorona, Mireia Teixidor, Carmen Orizales‐Lago, Vanesa Ocaña, Esther delBarco, Elena Carreras, Anna Suy, Manel Mendoza

Get full text